HYUNDAI BIOLAND Co.,Ltd. (KOSDAQ:052260)
South Korea flag South Korea · Delayed Price · Currency is KRW
4,790.00
0.00 (0.00%)
At close: Oct 2, 2025

HYUNDAI BIOLAND Statistics

Total Valuation

HYUNDAI BIOLAND has a market cap or net worth of KRW 140.55 billion. The enterprise value is 142.60 billion.

Market Cap140.55B
Enterprise Value 142.60B

Important Dates

The last earnings date was Monday, August 4, 2025.

Earnings Date Aug 4, 2025
Ex-Dividend Date Dec 27, 2024

Share Statistics

HYUNDAI BIOLAND has 30.00 million shares outstanding. The number of shares has increased by 14.28% in one year.

Current Share Class 30.00M
Shares Outstanding 30.00M
Shares Change (YoY) +14.28%
Shares Change (QoQ) n/a
Owned by Insiders (%) n/a
Owned by Institutions (%) 0.77%
Float 19.50M

Valuation Ratios

The trailing PE ratio is 11.24 and the forward PE ratio is 7.68.

PE Ratio 11.24
Forward PE 7.68
PS Ratio 1.11
PB Ratio 1.04
P/TBV Ratio 1.07
P/FCF Ratio 55.61
P/OCF Ratio 20.14
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 6.65, with an EV/FCF ratio of 56.42.

EV / Earnings -35.41
EV / Sales 1.13
EV / EBITDA 6.65
EV / EBIT 9.10
EV / FCF 56.42

Financial Position

The company has a current ratio of 3.86, with a Debt / Equity ratio of 0.08.

Current Ratio 3.86
Quick Ratio 1.48
Debt / Equity 0.08
Debt / EBITDA 0.50
Debt / FCF 4.21
Interest Coverage 30.52

Financial Efficiency

Return on equity (ROE) is 9.02% and return on invested capital (ROIC) is 6.09%.

Return on Equity (ROE) 9.02%
Return on Assets (ROA) 5.61%
Return on Invested Capital (ROIC) 6.09%
Return on Capital Employed (ROCE) 11.53%
Revenue Per Employee 370.02M
Profits Per Employee -11.81M
Employee Count 341
Asset Turnover 0.72
Inventory Turnover 1.50

Taxes

In the past 12 months, HYUNDAI BIOLAND has paid 1.44 billion in taxes.

Income Tax 1.44B
Effective Tax Rate 10.34%

Stock Price Statistics

The stock price has decreased by -14.00% in the last 52 weeks. The beta is 0.88, so HYUNDAI BIOLAND's price volatility has been lower than the market average.

Beta (5Y) 0.88
52-Week Price Change -14.00%
50-Day Moving Average 4,710.60
200-Day Moving Average 4,646.40
Relative Strength Index (RSI) 45.90
Average Volume (20 Days) 187,294

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, HYUNDAI BIOLAND had revenue of KRW 126.18 billion and -4.03 billion in losses. Loss per share was -134.25.

Revenue126.18B
Gross Profit 55.07B
Operating Income 15.67B
Pretax Income 13.94B
Net Income -4.03B
EBITDA 21.44B
EBIT 15.67B
Loss Per Share -134.25
Full Income Statement

Balance Sheet

The company has 8.59 billion in cash and 10.64 billion in debt, giving a net cash position of -2.05 billion or -68.18 per share.

Cash & Cash Equivalents 8.59B
Total Debt 10.64B
Net Cash -2.05B
Net Cash Per Share -68.18
Equity (Book Value) 134.65B
Book Value Per Share 4,488.31
Working Capital 60.39B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 6.98 billion and capital expenditures -4.45 billion, giving a free cash flow of 2.53 billion.

Operating Cash Flow 6.98B
Capital Expenditures -4.45B
Free Cash Flow 2.53B
FCF Per Share 84.25
Full Cash Flow Statement

Margins

Gross margin is 43.65%, with operating and profit margins of 12.42% and -3.19%.

Gross Margin 43.65%
Operating Margin 12.42%
Pretax Margin 11.05%
Profit Margin -3.19%
EBITDA Margin 16.99%
EBIT Margin 12.42%
FCF Margin 2.00%

Dividends & Yields

This stock pays an annual dividend of 35.00, which amounts to a dividend yield of 0.73%.

Dividend Per Share 35.00
Dividend Yield 0.73%
Dividend Growth (YoY) 100.00%
Years of Dividend Growth 1
Payout Ratio n/a
Buyback Yield -14.28%
Shareholder Yield -13.55%
Earnings Yield -2.87%
FCF Yield 1.80%
Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

The last stock split was on May 17, 2024. It was a forward split with a ratio of 2.

Last Split Date May 17, 2024
Split Type Forward
Split Ratio 2

Scores

HYUNDAI BIOLAND has an Altman Z-Score of 6.42 and a Piotroski F-Score of 5.

Altman Z-Score 6.42
Piotroski F-Score 5